A Synopsis of Guidance for Allergic Rhinitis Diagnosis and Management From ICAR 2023

Keyphrases

• Allergic Rhinitis 100%
• Monotherapy 40%
• Consensus Statement 40%
• International Consensus 40%
• Allergy 40%
• Recommendation Methodology 40%
• Evidence-based Review 40%
• Rhinology 40%
• Intranasal Corticosteroids 40%
• Allergen Immunotherapy 40%
• Disease Burden 20%
• Disease Risk Factors 20%
• Epidemiology 20%
• Antihistamines 20%
• Alternative Therapy 20%
• Patient Selection 20%
• Oral Corticosteroids 20%
• Aeroallergens 20%
• Combination Therapy 20%
• Intranasal 20%
• Unmet Needs 20%
• Primary Author 20%
• Environmental Control 20%
• Protective Factors 20%
• Sublingual 20%
• Consensus Document 20%
• Emerging Therapies 20%
• Pediatric Considerations 20%
• Factor Diagnosis 20%
• Oral Decongestant 20%
• Intranasal Antihistamines 20%
• Topical Areas 20%
• Factor Evaluation 20%
• Avoidance Control 20%
• Combination Pharmacotherapy 20%
• Healthcare Providers 20%
• Sublingual Tablet 20%

Medicine and Dentistry

• Allergic Rhinitis 100%
• Corticosteroid 60%
• Monotherapy 40%
• Histamine Antagonist 40%
• Rhinology 40%
• Oral 40%
• Pediatrics 20%
• Immunotherapy 20%
• Combination Therapy 20%
• Disease Burden 20%
• Pathophysiology 20%
• Cohort Effect 20%
• Aeroallergen 20%
• Desensitization 20%
• Protective Factor 20%
• Decongestant 20%
• Combination Drug Therapy 20%
• Subcutaneous Immunotherapy 20%
• Table Salt 20%
• Health Care Personnel 20%

Immunology and Microbiology

• Allergic Rhinitis 100%
• Immunotherapy 40%
• Allergen Immunotherapy 20%
• Disease Burden 20%
• Drug Therapy 20%
• Cohort Effect 20%
• Epidemiology 20%